scholarly journals P326Three-year clinical outcome after second-generation cryoballoon based pulmonary vein isolation for the treatment of paroxysmal and persistent atrial fibrillation: A two-center experience

EP Europace ◽  
2017 ◽  
Vol 19 (suppl_3) ◽  
pp. iii54-iii54
Author(s):  
C. Heeger ◽  
E. Wissner ◽  
M. Knoell ◽  
B. Knoop ◽  
B. Reissmann ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Clinical Outcome ◽  
Pulmonary Vein ◽  
Pulmonary Vein Isolation ◽  
Second Generation ◽  
Persistent Atrial Fibrillation

Five‐year experience with pulmonary vein isolation using the second‐generation cryoballoon for treatment of persistent atrial fibrillation

2018 ◽  
Vol 29 (11) ◽  
pp. 1500-1507 ◽  
Author(s):  
Ersan Akkaya ◽  
Alexander Berkowitsch ◽  
Sergej Zaltsberg ◽  
Harald Greiss ◽  
Christian W. Hamm ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Pulmonary Vein ◽  
Pulmonary Vein Isolation ◽  
Second Generation ◽  
Persistent Atrial Fibrillation

Common ostium of the left pulmonary veins – to freeze or not to freeze – that was the question?

2017 ◽  
Vol 4 (45) ◽  
pp. 33-34
Author(s):  
Michał Orczykowski
Keyword(s):  
Atrial Fibrillation ◽  
Pulmonary Vein ◽  
Pulmonary Vein Isolation ◽  
Second Generation ◽  
Pulmonary Veins ◽  
Persistent Atrial Fibrillation ◽  
Clinical Results ◽  
Common Pulmonary Vein

Second-generation cryoballoon (CB2) - based pulmonary vein isolation (PVI) has demonstrated encouraging clinical results in the treatment of paroxysmal (PAF) and persistent atrial fibrillation (PersAF). Nevertheless, the acute efficacy, safety, and long-term clinical results of CB2-based PVI in patients with a left common pulmonary vein (LCPV) are still a matter of debate. Commented paper by Heeger ChH, et al. analyzes this issue with some practical conclusions.

Sign in / Sign up

Export Citation Format

Share Document